A U.S. Patent on “Methods for Making Recombinant Proteins” was awarded to Coherus Biosciences on October 8th, 2019.  The present invention is a method of producing adalimumab in a mammalian cell culture comprising: a) inoculating a fed-batch bioreactor containing a cell culture production medium with mammalian cells comprising a nucleic acid encoding adalimumab or a fragment thereof wherein the mammalian cells are at a concentration from about 0.1 million to about 2 million cells/milliliter, wherein the production medium comprises glucose at an initial concentration from about 0.1 to about 0.9 grams/liter… Learn More